A practical and evidence-based approach to cardiovascular disease risk reduction.
Implementation of the numerous lifestyle and medical management options for secondary prevention of cardiovascular disease remains a daunting goal for primary care physicians and cardiologists alike. Despite the existence of expert consensus guidelines on cardiovascular prevention by the American College of Cardiology and the American Heart Association, therapies known to improve patient care and decrease morbidity and mortality remain underutilized. This review attempts to simplify cardiovascular risk reduction by summarizing key clinical trials in an "ABC" format. We believe that if health care providers and patients use such a format, important lifestyle and pharmacologic options will more likely be addressed.
Gluckman
Ty J
TJ
Ciccarone Preventive Cardiology Center, Cardiology Division, Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Baranowski
Bryan
B
Ashen
M Dominique
MD
Henrikson
Charles A
CA
McAllister
Marc
M
Braunstein
Joel B
JB
Blumenthal
Roger S
RS
D000925:Anticoagulants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008019:Life Style; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D040242:Risk Reduction Behavior
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D002784:Cholesterol